Pharma companies seeking approval for drugs along with companion diagnostics could see quicker FDA decisions as the agency moves toward a stricter preapproval path for the diagnostic portion of companion products.
FDA Wants Harder Approval Standards for Drug-Device Combo Diagnostics
- Post author:Sam
- Post published:April 7, 2016
- Post category:Washington Drug Letter